{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:33:33Z","timestamp":1794018813776,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ijantimicag.2010.11.028","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:25:30Z","timestamp":1296120330000},"page":"405-409","source":"Crossref","is-referenced-by-count":21,"title":["Strategies to overcome extended-spectrum \u03b2-lactamases (ESBLs) and AmpC \u03b2-lactamases in shigellae"],"prefix":"10.1016","volume":"37","author":[{"given":"David M.","family":"Livermore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazad","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tue","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0005","unstructured":"World Health Organization. Shigella. Geneva: WHO; 2010. http:\/\/www.who.int\/vaccine_research\/diseases\/shigella\/en [accessed 9 December 2010]."},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0010","first-page":"CD006784","article-title":"Antibiotic therapy for Shigella dysentery","author":"Christopher","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/AAC.29.4.645","article-title":"Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial","volume":"29","author":"Kabir","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00365528909091332","article-title":"A randomized, controlled, single-blind study comparing furazolidone with trimethoprim\u2013sulfamethoxazole in the empirical treatment of acute invasive diarrhea","volume":"169","author":"Rodriguez","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijantimicag.2007.11.016","article-title":"CMY-2-type plasmid-mediated AmpC \u03b2-lactamase finally emerging in Argentina","volume":"31","author":"Rapoport","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0030","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/JCM.43.6.2608-2612.2005","article-title":"Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC \u03b2-lactamase resistance in S. sonnei","volume":"43","author":"Huang","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3343\/kjlm.2006.26.3.168","article-title":"Clinical characteristics of extended-spectrum \u03b2-lactamase-producing Shigella sonnei infection outbreaked in Chungju area","volume":"26","author":"Hong","year":"2006","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1574-6968.2007.01017.x","article-title":"Phenotypic and molecular characterization of TEM-116 extended-spectrum \u03b2-lactamase produced by a Shigella flexneri clinical isolate from chickens","volume":"279","author":"Hu","year":"2008","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0045","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1371\/journal.pntd.0000702","article-title":"The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. circulating in southern Vietnam","volume":"4","author":"Nguyen","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7883\/yoken.JJID.2008.135","article-title":"CTX-M-3 type \u03b2-lactamase producing Shigella sonnei isolates from pediatric bacillary dysentery cases","volume":"61","author":"Acikgoz","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0055","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1179\/136485907X193860","article-title":"First detection and sequence analysis of the bla-CTX-M-15 gene in Lebanese isolates of extended-spectrum-\u03b2-lactamase-producing Shigella sonnei","volume":"101","author":"Matar","year":"2007","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0060","first-page":"300","article-title":"Molecular characterization of ESBL-producing Shigella sonnei isolates from patients with bacilliary dysentery in Lebanon","volume":"3","author":"Sabra","year":"2009","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10096-007-0263-y","article-title":"Extended-spectrum \u03b2-lactamase-producing Shigella strains in Israel, 2000\u20132004","volume":"26","author":"Vasilev","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijantimicag.2005.02.016","article-title":"Extended-spectrum \u03b2-lactamases in Shigella flexneri from Argentina: first report of TOHO-1 outside Japan","volume":"25","author":"Andres","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0075","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1286-4579(02)01637-4","article-title":"Escherichia coli in disguise: molecular origins of Shigella","volume":"4","author":"Lan","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0080","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.45.10.2831-2837.2001","article-title":"Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent \u03b2-lactamases","volume":"45","author":"Livermore","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jac\/dkl456","article-title":"Wide geographic spread of diverse acquired AmpC \u03b2-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland","volume":"59","author":"Woodford","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0090","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial testing of bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0095","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/JCM.32.10.2553-2558.1994","article-title":"Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 \u03b2-lactamase and which were isolated in 14 French hospitals","volume":"32","author":"Arlet","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0100","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/jac\/dkh413","article-title":"Extended-spectrum \u03b2-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh","volume":"54","author":"Rahman","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/00365529409094842","article-title":"Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children","volume":"29","author":"Alam","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0110","first-page":"644","article-title":"Ceftibuten and trimethoprim\u2013sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease","volume":"11","author":"Prado","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3476(05)80867-4","article-title":"A randomized, double-blind study comparing cefixime and trimethoprim\u2013sulfamethoxazole in the treatment of childhood shigellosis","volume":"123","author":"Ashkenazi","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-123-7-199510010-00005","article-title":"Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults","volume":"123","author":"Salam","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.028_bib0125","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jac\/23.4.547","article-title":"Bactericidal effects of amoxycillin\/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies","volume":"23","author":"Stokes","year":"1989","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910005546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910005546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:15:37Z","timestamp":1685924137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910005546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0924857910005546"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.11.028","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}